Richard is Professor of Infectious Disease Modelling in the Centre for the Mathematical Modelling of Infectious Diseases and the TB Centre at the London School of Hygiene and Tropical Medicine. He leads the LSHTM TB Modelling Group. His research focus is the mathematical and statistical modelling of the transmission and control of infectious diseases, particularly TB and HIV.
TB MAC’s main decision-making body is its Steering Committee.
David is an Associate Professor at Johns Hopkins University, in the Bloomberg School of Public Health. He is an epidemiologist and practising general internist whose research merges expertise in classical epidemiology, economic evaluation, infectious disease modelling, and translation of science into policy. Other interests include heterogeneity in TB transmission, active TB case-finding, development of “user-friendly” modelling tools for TB, costing of HIV prevention interventions, and evaluation of TB therapeutics and vaccines.
Anna is a Professor of Health Economics at the London School of Hygiene and Tropical Medicine. She leads the economic evaluation and priority setting group in the Department of Global Health at LSHTM and as part of the Centre for Health Economics in London (CHIL). She specialises in the economics of HIV, sexual and reproductive health, gender based violence prevention and tuberculosis (TB).
Ted is an Associate Professor at the Yale School of Public Health. He is an infectious disease epidemiologist with a primary research focus on tuberculosis. He is particularly interested in understanding how TB drug-resistance and medical comorbidities such as HIV frustrate current efforts to control epidemics, with an ultimate goal of developing more effective approaches to limit the morbidity caused by this pathogen.
Anna is a Senior Research Manager of the HIV/TB center at the Institute for Disease Modeling, and an Affiliate Assistant Professor of Global Health at the University of Washington. Her modelling research focuses on HIV transmission dynamics and impact evaluation of biomedical and programmatic improvements to HIV care and prevention.
Michael is the director of the Technical Services Division at KNCV Tuberculosis Foundation, covering TB program support, implementation research and policy development. He has particular interests in product adoption and evaluation of innovation in delivery.
Geoff is a Deputy Director of Global Development and Global Health at the Bill and Melinda Gates Foundation. He works on improving the efficiency and effectiveness of health programs, with a particular focus on HIV. Prior to the foundation, he was a professor in the Department of Infectious Disease Epidemiology at Imperial College London and a Reader at Oxford University working on the epidemiology, evolution and control of sexually transmitted infections. He has served as chair of the UNAIDS Reference Group on Estimates Models and Projections and on a number of Institute of Medicine and Wellcome Trust panels.
Nick is an Assistant Professor of Global Health at the Harvard Chan School of Public Health, and faculty of the Harvard Center for Health Decision Science. He uses decision science and quantitative research to understand the consequences of major policy change, and help design effective disease control programs where resources are limited. His research combines empirical data with mathematical modeling to examine infectious disease control policy in high burden settings, currently focusing on the intersection of HIV and TB epidemics in sub-Saharan Africa and other high-burden settings.
Frank is a Professor of Global Health at the University of Amsterdam, Chair of the Executive board of AIGHD and a Scientific Advisor at KNCV Tuberculosis Foundation. His scientific interest is in multidisciplinary approaches to problems at the interface of biomedical aspects of infectious diseases, socioeconomic context and control policy.
Chris is a Director of Strategy in the Office of the Director General at the World Health Organisation, and a Visiting Professor of Zoology at the University of Oxford. His research has focused on the large-scale dynamics of tuberculosis, HIV/AIDS, malaria, Ebola and other infectious diseases. Amongst other topics, he has investigated the rise of tuberculosis linked to HIV/AIDS in Sub-Saharan Africa, and the spread and containment of antimicrobial resistance.
Philip is the Malaria Program Director at the Bill and Melinda Gates Foundation. Previously, he served as director of research at the Institute for Disease Modeling (IDM). There, he helped develop computer simulations of malaria, polio, and other disease transmission dynamics to assist public health professionals and other scientists in planning the eradication of different diseases. Philip received a Special Achievement Award by a Hertz Fellow in 2009 for his work on malaria modeling.
Martien is Professor of Epidemiology at the University of Amsterdam and a Director at The Centers for Disease Control and Prevention (CDC) Western Branch, Kenya, based at KEMRI’s Centre for Global Health Research. His main interests are the epidemiology and control of infectious diseases with a special interest in tuberculosis and HIV. His tuberculosis research focused on the molecular epidemiology of tuberculosis in low and high incidence settings and on disease burden estimates and their trends.
Damian is a Senior Program Officer at the Bill & Melinda Gates Foundation, where he works on the cost-effectiveness of health interventions and technologies. His portfolio of grants includes efforts to set disease control priorities globally, as well as assessments of the cost-effectiveness of new vaccines, and HIV treatment and prevention interventions at the national level.
David is a Senior Program Officer in Decision Sciences at the Bill and Melinda Gates Foundation, Professor of Modeling & Health Economics at the Burnet Institute, and founder of the Optima Consortium for Decision Science. His dominant focus was on allocative efficiency for major infectious diseases (with a special focus on HIV).